跳至主要内容
临床试验/CTRI/2023/04/051712
CTRI/2023/04/051712进行中(未招募)Unknown

A prospective study to evaluate the efficacy of oral pilocarpine in radiation induced Xerostomia among patients with head and neck squamous cell carcinoma - PRIX

SVIMS0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
Unknown
状态
进行中(未招募)
发起方
SVIMS

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Histo pathologically proven squamous cell carcinoma of head & neck [oral cavity, oropharynx, nasopharynx, hypopharynx, larynx]
  • Age : 18 -70 years
  • Patients with ECOG performance status of 0-2
  • Stage I to IVb [AJCC : 8th edition]
  • Patients receiving definitive or adjuvant RT (postoperative cases) with or without concurrent chemotherapy
  • Patients who have given approved informed consent

排除标准

  • Patients previously treated with radiotherapy to head & neck region
  • Patients receiving palliative radiotherapy
  • Cancers of salivary glands
  • Patients with surgical removal of parotid / submandibular glands
  • Patients with ECOG performance status of 3-4 [Appendix II]
  • Patients allergic to pilocarpine
  • Patients receiving tricyclic antidepressants, beta blockers & anti histaminics
  • Patients suffering with closed angle glaucoma, asthma, COPD & coronary artery disease
  • Pregnant & lactating women

研究者

发起方
SVIMS

相似试验